Skip to main content

Korea Investment Partners — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

293
Companies
$6.1B
Total invested
$20.9M
Avg. check
56
Industries
Health Care 9Biotechnology 8Artificial Intelligence (AI) 5Medical Device 3Medical 3Oncology 3+50 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 293
Adler
April 2024

Adler makes 3D web - 1 Person, 1 Virtual Universe

Developer Platform · Seoul$359K Seed
StealthMole
March 2024

StealthMole is an AI-powered dark web intelligence firm that focuses on monitoring cyber dangers and detecting criminality.

Artificial Intelligence (AI) · Singapore$7.0M Series A
Agilis Robotics
March 2024

Agilis Robotics develops flexible robotic instruments for endoluminal surgery.

Hardware · Sha Tin$10.0M Series A
Order of Meta
January 2024

Order of Meta is a gaming studio brought to professional game creators.

Video Games · Helsinki$3.3M Seed
Kek Entertainment
November 2023

Kek Entertainment makes multiplayer mobile games.

Gaming · Limassol$8.0M Seed
Getcha
November 2023

Getcha is a car purchase, long-term rental, lease, test ride, and car consulting company.

Automotive · Kangnam$2.7M Series B
Actym Therapeutics, Inc.
October 2023

Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.

Biotechnology · Berkeley$25.5M Series A
Geneos Therapeutics
September 2023

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Biotechnology · Plymouth Meeting$5.0M Series A
Sky Labs
September 2023

Skylabs is developing a healthcare wearable ring as part of its mission to develop a mobile personal health analysis and prediction system.

Clinical Trials · Seongnam$15.5M Series C
Saige Research
September 2023

Saige Research specializes in artificial intelligence solutions for industrial inspection and quality control.

Artificial Intelligence (AI) · Seoul$11.6M Series B
ABL Bio
September 2023

ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases.

Biotechnology · Seongnam$3.0M Venture - Series Unknown
Zendure
June 2023

Zendure is the pioneer of the world’s first plug-and-play balcony energy storage system.

CleanTech · Düsseldorf$13.9M Series A
Lime AI
May 2023

Lime provides professional stress management using AI

Artificial Intelligence (AI) · Palo Alto$973K Seed
CashWalk
April 2023

CashWalk is a fitness tracking app that helps user to track their fitness activity by providing data and analytics from the past.

Apps · San Jose$23.0M Seed
Prokarium
February 2023

Prokarium is biopharmaceutical company leading the oncology field of microbial immunotherapy.

Biotechnology · London$30.0M Series B
Phantom AI
February 2023

Phantom AI creates and delivers an advanced computer vision and related ADAS technology to automotive OEMs and Tier 1s.

Artificial Intelligence (AI) · Mountain View$41.5M Series C
Univercells
October 2022

Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions

Biotechnology · Gosselies$43.3M Series D
Monese
September 2022

Monese is a mobile-only, multi-currency account banking option that offers a fully complete and localized banking experience.

Banking · London$35.0M Venture - Series Unknown
Swit
September 2022

Swit is a collaboration suite for Teams.

Collaboration · San Francisco$4.0M Corporate Round
N3TWORK
May 2022

Creating, publishing, and scaling the very best in mobile games.

Analytics · San Francisco$46.0M Series A
Adriel
March 2022

Adriel is a digital marketing platform that monitors and controls paid advertising across multiple channels.

Advertising · Newark$13.0M Series B
OncXerna Therapeutics
March 2022

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.

Biopharma · Waltham$30.0M Venture - Series Unknown
OncoMyx Therapeutics
December 2021

OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.

Biotechnology · Phoenix$50.0M Series B
PDC*line Pharma
December 2021

PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of plasmacytoid dendritic cells.

Biotechnology · La Tronche$13.3M Series B

Where Korea Investment Partners invests

Health Care9
Biotechnology8
Artificial Intelligence (AI)5
Medical Device3
Medical3
Oncology3

About Korea Investment Partners's portfolio

How many companies has Korea Investment Partners invested in?▸

Korea Investment Partners has invested in 293 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Korea Investment Partners invest in?▸

Korea Investment Partners's top investment sectors include Health Care, Biotechnology, Artificial Intelligence (AI), Medical Device, Medical. The firm invests across 56 different industry categories.

What is Korea Investment Partners's largest investment?▸

Among tracked funding rounds, OncoMyx Therapeutics received $50.0M in a Series B round. Korea Investment Partners's total known invested capital is $6.1B.

What is the average investment size for Korea Investment Partners?▸

Korea Investment Partners's average investment size is $20.9M across its portfolio of 293 companies.

What are Korea Investment Partners's most recent investments?▸

Recent Korea Investment Partners portfolio additions include Adler, StealthMole, Agilis Robotics, Order of Meta, Kek Entertainment. These companies were founded in 2020 or later.

Reach the founders behind these 293 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →